Biotech
Infectious Disease
Dr. Phillip S. Pang, MD
|
|
Give Review
Doctor Phillip S. Pang, MD works in the field of Infectious Disease. He studied medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a one of the best medicals schools. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care Phillip S. Pang, MD is a published doctor. He published 19 publications, including: 'Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.'
Publications
- Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.
- Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection.
- Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.
- Phosphatidylinositol 4,5-bisphosphate is an HCV NS5A Ligand and Mediates Replication of the Viral Genome.
- Lack of a Clinically Important Pharmacokinetic Interaction Between Sofosbuvir or Ledipasvir and Hormonal Oral Contraceptives Norgestimate/Ethinyl Estradiol in HCV-Unin...
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis.
- Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection.
- Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection.
- Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infect...
- Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B.
- Structural Map of a MicroRNA-122:HCV Complex.
- Simplified RNA secondary structure mapping by automation of SHAPE data analysis.
- The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C.
- The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.
- Prediction of functional tertiary interactions and intermolecular interfaces from primary sequence data.
- Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.
- The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding.
Schools
Columbia University College of Physicians And Surgeons
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Stanford University -
Columbia University College of Physicians & Surgeons
Hospital
-
VA Palo Alto Health Care System
Helpful Reviews
Similar Doctors
|
|
Dr. Lucy S. Tompkins, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian G. Blackburn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gina A. Suh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alicia H. Chang, MD |
|
|
Dr. Dora Y. Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lily M. Horng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sulggi A. Lee, MD |
|
|
Dr. Gary K. Schoolnik, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert W. Shafer, MD |
|
|
Dr. Paul R. Waldron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carlos A. Gomez Alvarez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine A. Blish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abraham Verghese, MD
This Doctor is OpenDoctor Recommended.
|